Optic neuritis is a rare autoimmune disease characterized by the inflammation of the optic nerve. The Food and Drug Administration (FDA) has granted Orphan Drug designation to TRE-515 for the ...

Features of anti-MOG optic neuritis include bilateral disease, frequent relapses and optic disc edema. ... NMO, on the other hand, typically affects the optic chiasm and posterior optic pathways.

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpo ...

Optic neuritis (ON) is an inflammation that damages your optic nerve. It can cause vision loss and pain when you move your eyes. As the inflammation goes away, your symptoms usually get better ...

BARCELONA — The investigational monoclonal antibody BIIB033 (Biogen) appears not only to improve optic nerve latency in the affected eye of patients with acute optic neuritis (AON), often one of ...

To document the etiology, clinical presentation, and visual prognosis of optic neuritis in Taiwanese children. Retrospectively reviewed children younger than 18 years old with optic neuritis in ...

Optic neuritis is a common symptom of multiple sclerosis (MS) that affects your eyes and vision. Learn more about the symptoms, causes, diagnosis, treatment, and complications of optic neuritis.

My daughter, my oldest baby, just turned 21. Six weeks after the joy of her birth came a not so pleasant gift: my diagnosis of multiple sclerosis. Eighteen months later she was an active toddler ...

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential ...

Oculis Holding AG. Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a ...

The Phase 2 ACUITY (Acute OptiC NeUrITis of DemYelinating Origin) trial was a randomized, double-blind, placebo-controlled, multi-center trial, designed to evaluate OCS-05 (2mg/kg/day or 3mg/kg ...